Figure 4. Forest plot comparing binary (A) and continuous (B) maternal outcomes between IPTp regimens.
All estimates reflect unadjusted differences between arms, except for mean MUAC and gestational weight gain, which adjusted for enrolment values. Weighted prevalence and means for each outcome were calculated using a restricted maximum likelihood random-effects model.
Abbreviations: CI=confidence interval; DP=dihydroartemisinin-piperaquine; Hb=haemoglobin; MD=mean difference; MUAC=mid-upper arm circumference; RR=relative risk ratio; SP=sulfadoxine-pyrimethamine
1 Maternal anaemia summary estimates derived from seven of eight studies (except the Gutman unpublished study which only had haemoglobin measurements at delivery); Maternal MUAC summary estimates derived from five of eight studies (except the Kakuru 2016; Kajubi 2019; and Mlugu 2021 studies)